Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy.
Filippo CreaHolger ThieleDirk SibbingOlivier BarthélémyJohann BauersachsDeepak L BhattPaul DendaleMaria DorobantuThor EdvardsenThierry FolliguetChris P GaleMartine GilardAlexander JobsPeter JüniEkaterini LambrinouBasil S LewisJulinda MehilliEmanuele MeligaBéla MerkelyChristian MuellerMarco RoffiFrans H RuttenGeorge C M SiontisEmanuele BarbatoJean-Philippe ColletEvangelos GiannitsisChristian W HammMichael BöhmJan H CornelJosé Luis FerreiroNorbert FreyKurt HuberJacek KubicaEliano P NavareseRoxana MehranJoao MoraisRobert F StoreyMarco ValgimigliPascal VranckxStefan JamesPublished in: European heart journal (2021)
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- chronic kidney disease
- coronary artery disease
- heart failure
- coronary artery bypass grafting
- atrial fibrillation
- patient reported outcomes
- combination therapy
- left ventricular
- replacement therapy